2018 Q4 Form 10-Q Financial Statement
#000086266819000003 Filed on February 14, 2019
Income Statement
Concept | 2018 Q4 | 2018 Q3 | 2017 Q4 |
---|---|---|---|
Revenue | $2.419M | $2.258M | $3.383M |
YoY Change | -28.5% | -14.12% | 6.97% |
Cost Of Revenue | $1.280M | $1.203M | $1.838M |
YoY Change | -30.34% | -18.0% | 7.34% |
Gross Profit | $1.139M | $1.055M | $1.545M |
YoY Change | -26.31% | -9.21% | 6.53% |
Gross Profit Margin | 47.08% | 46.73% | 45.68% |
Selling, General & Admin | $1.139M | $1.002M | $1.193M |
YoY Change | -4.5% | 0.58% | -1.18% |
% of Gross Profit | 100.02% | 94.98% | 77.18% |
Research & Development | $226.3K | $96.41K | $107.5K |
YoY Change | 110.53% | -50.07% | -62.43% |
% of Gross Profit | 19.88% | 9.14% | 6.96% |
Depreciation & Amortization | $14.93K | $13.19K | $10.00K |
YoY Change | 49.3% | 11.23% | 0.0% |
% of Gross Profit | 1.31% | 1.25% | 0.65% |
Operating Expenses | $1.365M | $1.099M | $1.300M |
YoY Change | 5.01% | -7.64% | -12.92% |
Operating Profit | -$226.5K | -$43.40K | $245.1K |
YoY Change | -192.42% | 59.12% | -676.66% |
Interest Expense | $3.422K | $6.851K | $34.56K |
YoY Change | -90.1% | -79.52% | 53.68% |
% of Operating Profit | 14.1% | ||
Other Income/Expense, Net | $8.564K | -$4.341K | $466.1K |
YoY Change | -98.16% | -86.94% | -2176.37% |
Pretax Income | -$218.0K | -$50.00K | $710.0K |
YoY Change | -130.7% | -16.67% | -1283.33% |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$218.0K | -$47.74K | $711.2K |
YoY Change | -130.65% | -21.12% | -1194.91% |
Net Earnings / Revenue | -9.01% | -2.11% | 21.02% |
Basic Earnings Per Share | -$0.03 | -$0.01 | $0.09 |
Diluted Earnings Per Share | -$0.03 | -$0.01 | $0.09 |
COMMON SHARES | |||
Basic Shares Outstanding | 7.415M shares | 7.415M shares | 7.551M shares |
Diluted Shares Outstanding | 7.415M shares | 7.415M shares | 7.551M shares |
Balance Sheet
Concept | 2018 Q4 | 2018 Q3 | 2017 Q4 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $652.5K | $910.0K | $790.0K |
YoY Change | -17.4% | 111.63% | 46.3% |
Cash & Equivalents | $652.5K | $415.8K | $788.2K |
Short-Term Investments | |||
Other Short-Term Assets | $237.6K | $257.0K | $197.0K |
YoY Change | 20.64% | 11.53% | -40.69% |
Inventory | $1.969M | $1.969M | $2.067M |
Prepaid Expenses | |||
Receivables | $1.300M | $1.422M | $1.926M |
Other Receivables | $0.00 | $0.00 | $0.00 |
Total Short-Term Assets | $4.410M | $4.610M | $4.979M |
YoY Change | -11.42% | 9.54% | 8.66% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $67.67K | $74.50K | $43.93K |
YoY Change | 54.04% | 47.36% | -34.7% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | $0.00 | ||
YoY Change | |||
Total Long-Term Assets | $824.2K | $835.9K | $820.1K |
YoY Change | 0.5% | 0.52% | -15.3% |
TOTAL ASSETS | |||
Total Short-Term Assets | $4.410M | $4.610M | $4.979M |
Total Long-Term Assets | $824.2K | $835.9K | $820.1K |
Total Assets | $5.234M | $5.446M | $5.799M |
YoY Change | -9.73% | 8.05% | 4.48% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $740.2K | $679.0K | $945.3K |
YoY Change | -21.7% | -33.22% | -22.29% |
Accrued Expenses | $736.4K | $744.2K | $1.221M |
YoY Change | -39.7% | -29.34% | 12.28% |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $201.6K | $201.6K | $645.0K |
YoY Change | -68.75% | -76.83% | 158.0% |
Long-Term Debt Due | $3.490K | $0.00 | |
YoY Change | |||
Total Short-Term Liabilities | $2.341M | $2.321M | $3.199M |
YoY Change | -26.82% | -25.99% | -2.53% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $16.41K | $20.00K | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $730.3K | $740.0K | $770.0K |
YoY Change | -5.15% | -5.13% | -6.1% |
Total Long-Term Liabilities | $746.7K | $760.3K | $765.3K |
YoY Change | -2.42% | -2.63% | -6.4% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $2.341M | $2.321M | $3.199M |
Total Long-Term Liabilities | $746.7K | $760.3K | $765.3K |
Total Liabilities | $3.088M | $3.082M | $3.964M |
YoY Change | -22.11% | -21.33% | -3.3% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$68.21M | -$67.99M | -$67.88M |
YoY Change | 0.49% | -0.87% | -0.56% |
Common Stock | $7.415K | $7.415K | $7.551K |
YoY Change | -1.8% | -1.8% | 0.0% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $2.147M | $2.365M | $1.834M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $5.234M | $5.446M | $5.799M |
YoY Change | -9.73% | 8.05% | 4.48% |
Cashflow Statement
Concept | 2018 Q4 | 2018 Q3 | 2017 Q4 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$218.0K | -$47.74K | $711.2K |
YoY Change | -130.65% | -21.12% | -1194.91% |
Depreciation, Depletion And Amortization | $14.93K | $13.19K | $10.00K |
YoY Change | 49.3% | 11.23% | 0.0% |
Cash From Operating Activities | -$258.7K | $11.83K | -$110.0K |
YoY Change | 135.17% | -106.96% | -68.57% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $3.490K | -$10.00K | $0.00 |
YoY Change | 0.0% | ||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $0.00 | $500.0K | |
YoY Change | -100.0% | ||
Cash From Investing Activities | $3.490K | -$6.506K | $500.0K |
YoY Change | -99.3% | -55.76% | |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -4.710K | $36.07K | -40.00K |
YoY Change | -88.23% | -51.91% | -107.69% |
NET CHANGE | |||
Cash From Operating Activities | -258.7K | $11.83K | -110.0K |
Cash From Investing Activities | 3.490K | -$6.506K | 500.0K |
Cash From Financing Activities | -4.710K | $36.07K | -40.00K |
Net Change In Cash | -259.9K | $41.40K | 350.0K |
YoY Change | -174.26% | -136.24% | 105.88% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$258.7K | $11.83K | -$110.0K |
Capital Expenditures | $3.490K | -$10.00K | $0.00 |
Free Cash Flow | -$262.2K | $21.83K | -$110.0K |
YoY Change | 138.35% | -113.65% | -68.57% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2019 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--06-30 | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2018-12-31 | ||
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0000862668 | ||
CY2017Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
788211 | USD |
CY2018Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1124002 | USD |
CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
904090 | USD |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
244093 | USD | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-219912 | USD | |
us-gaap |
Common Stock Conversion Basis
CommonStockConversionBasis
|
4300000 | ||
CY2018Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2018Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2018Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
35000000 | shares |
CY2018Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
35000000 | shares |
CY2018Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7415329 | shares |
CY2018Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
7415329 | shares |
CY2018Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7415329 | shares |
CY2018Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
7415329 | shares |
dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | ||
CY2018Q4 | dei |
Entity Public Float
EntityPublicFloat
|
1585000 | USD |
dei |
Entity Registrant Name
EntityRegistrantName
|
ESCALON MEDICAL CORP. | ||
CY2018Q4 | esmc |
Accruedinterestrelatedparty
Accruedinterestrelatedparty
|
112389 | USD |
esmc |
Increasedecreaseinliabilitiesofdiscontinuedoperations
Increasedecreaseinliabilitiesofdiscontinuedoperations
|
4707 | USD | |
esmc |
Increasedecreaseinliabilitiesofdiscontinuedoperations
Increasedecreaseinliabilitiesofdiscontinuedoperations
|
-1029 | USD | |
CY2018Q3 | esmc |
Maximum Maturity Of Highly Liquid Investments Period
MaximumMaturityOfHighlyLiquidInvestmentsPeriod
|
P90D | |
CY2018Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
528844 | USD |
CY2018Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
740179 | USD |
CY2018Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1387133 | USD |
CY2018Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1299769 | USD |
CY2018Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
874421 | USD |
CY2018Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
736417 | USD |
CY2018Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
69702043 | USD |
CY2018Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
69702043 | USD |
CY2017Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
367500 | shares |
CY2018Q3 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4513000 | shares |
CY2018Q2 | us-gaap |
Assets
Assets
|
5426793 | USD |
CY2018Q4 | us-gaap |
Assets
Assets
|
5234333 | USD |
CY2018Q2 | us-gaap |
Assets Current
AssetsCurrent
|
4584169 | USD |
CY2018Q4 | us-gaap |
Assets Current
AssetsCurrent
|
4410130 | USD |
CY2017Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
544118 | USD |
CY2017Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
788211 | USD |
CY2018Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
874002 | USD |
CY2018Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
652518 | USD |
CY2017Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
544118 | USD |
CY2018Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
7415329 | shares |
CY2018Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
7415 | USD |
CY2018Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
7415 | USD |
CY2018 | us-gaap |
Concentration Risk Credit Risk Financial Instruments
ConcentrationRiskCreditRiskFinancialInstruments
|
0.11 | |
us-gaap |
Concentration Risk Credit Risk Financial Instruments
ConcentrationRiskCreditRiskFinancialInstruments
|
0.14 | ||
us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
0 | USD | |
CY2018Q4 | us-gaap |
Concentration Risk Customer
ConcentrationRiskCustomer
|
0.1 | |
CY2017Q4 | us-gaap |
Concentration Risk Supplier
ConcentrationRiskSupplier
|
0.36 | |
us-gaap |
Concentration Risk Supplier
ConcentrationRiskSupplier
|
0.37 | ||
CY2018Q4 | us-gaap |
Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
|
2.15 | shares |
CY2017Q4 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
1837758 | USD |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
3305068 | USD | |
CY2018Q4 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
1280173 | USD |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
2483306 | USD | |
CY2017Q4 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
3137891 | USD |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
5794787 | USD | |
CY2018Q4 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
2645427 | USD |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
4947205 | USD | |
CY2018Q2 | us-gaap |
Deferred Revenue
DeferredRevenue
|
481000 | USD |
CY2018Q4 | us-gaap |
Deferred Revenue
DeferredRevenue
|
466000 | USD |
CY2017Q4 | us-gaap |
Deferred Revenue Additions
DeferredRevenueAdditions
|
244000 | USD |
us-gaap |
Deferred Revenue Additions
DeferredRevenueAdditions
|
509000 | USD | |
CY2018Q4 | us-gaap |
Deferred Revenue Additions
DeferredRevenueAdditions
|
207000 | USD |
us-gaap |
Deferred Revenue Additions
DeferredRevenueAdditions
|
459000 | USD | |
CY2018Q2 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
481180 | USD |
CY2018Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
466016 | USD |
CY2017Q4 | us-gaap |
Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
|
211000 | USD |
us-gaap |
Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
|
416000 | USD | |
CY2018Q4 | us-gaap |
Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
|
239000 | USD |
us-gaap |
Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
|
474000 | USD | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
23392 | USD | |
us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
24927 | USD | |
CY2018Q4 | us-gaap |
Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
|
-217983 | USD |
CY2018Q2 | us-gaap |
Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
|
0.01 | |
CY2018Q4 | us-gaap |
Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
|
0.0227 | |
CY2018Q1 | us-gaap |
Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
|
0.03 | |
CY2017Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.09 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.09 | ||
CY2018Q4 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.03 | |
us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.04 | ||
CY2017Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.09 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.09 | ||
CY2018Q4 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.03 | |
us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.04 | ||
CY2018Q4 | us-gaap |
Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
|
0.3670 | |
CY2018Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
161350 | USD |
CY2018Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
151525 | USD |
us-gaap |
Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
|
500000 | USD | |
CY2017Q4 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.09 | |
us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
0.09 | ||
CY2018Q4 | us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.03 | |
us-gaap |
Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
|
-0.04 | ||
CY2018Q2 | us-gaap |
Inventory Net
InventoryNet
|
1823414 | USD |
CY2017Q4 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0.09 | |
us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
0.09 | ||
CY2018Q4 | us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
-0.03 | |
us-gaap |
Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
-0.04 | ||
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
119658 | USD | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
73331 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
442308 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-87364 | USD | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
33621 | USD | |
us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
-15164 | USD | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
149476 | USD | |
us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
145257 | USD | |
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-12596 | USD | |
us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-12020 | USD | |
us-gaap |
Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
|
-34090 | USD | |
us-gaap |
Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
|
-19167 | USD | |
CY2017Q4 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
0 | shares |
us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
0 | shares | |
CY2018Q4 | us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
0 | shares |
us-gaap |
Incremental Common Shares Attributable To Conversion Of Preferred Stock
IncrementalCommonSharesAttributableToConversionOfPreferredStock
|
0 | shares | |
CY2018Q2 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
605006 | USD |
CY2018Q4 | us-gaap |
Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
|
605006 | USD |
CY2017Q4 | us-gaap |
Interest Expense
InterestExpense
|
34562 | USD |
us-gaap |
Interest Expense
InterestExpense
|
68010 | USD | |
CY2018Q4 | us-gaap |
Interest Expense
InterestExpense
|
3422 | USD |
us-gaap |
Interest Expense
InterestExpense
|
10273 | USD | |
CY2017Q4 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
24387 | USD |
us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
47499 | USD | |
CY2018Q4 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
0 | USD |
us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
0 | USD | |
CY2017Q3 | us-gaap |
Interest Paid
InterestPaid
|
17355 | USD |
CY2018Q3 | us-gaap |
Interest Paid
InterestPaid
|
39070 | USD |
CY2018Q2 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
978000 | USD |
CY2018Q3 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
944000 | USD |
CY2018Q2 | us-gaap |
Inventory Net
InventoryNet
|
1823000 | USD |
CY2018Q3 | us-gaap |
Inventory Net
InventoryNet
|
1969000 | USD |
CY2018Q4 | us-gaap |
Inventory Net
InventoryNet
|
1968671 | USD |
CY2018Q2 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
653000 | USD |
CY2018Q3 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
707000 | USD |
CY2018Q2 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
192000 | USD |
CY2018Q3 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
320000 | USD |
CY2017Q4 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
645 | USD |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
844 | USD | |
CY2018Q4 | us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
864 | USD |
us-gaap |
Investment Income Interest
InvestmentIncomeInterest
|
3374 | USD | |
CY2018Q2 | us-gaap |
Liabilities
Liabilities
|
3014538 | USD |
CY2017Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
711220 | USD |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
650699 | USD | |
CY2018Q4 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
8564 | USD |
CY2018Q4 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-230989 | USD |
us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-291730 | USD | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
4223 | USD | |
CY2017Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
245137 | USD |
CY2017Q4 | us-gaap |
Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
|
711220 | USD |
us-gaap |
Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
|
650699 | USD | |
CY2018Q4 | us-gaap |
Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
|
-230989 | USD |
us-gaap |
Net Income Loss From Continuing Operations Available To Common Shareholders Basic
NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
|
-291730 | USD | |
CY2017Q4 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
466083 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
217865 | USD | |
CY2018Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-226547 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-269942 | USD | |
CY2018Q4 | us-gaap |
Liabilities
Liabilities
|
3087797 | USD |
CY2018Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5426793 | USD |
CY2018Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
5234333 | USD |
CY2018Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2247021 | USD |
CY2018Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
2341072 | USD |
CY2018Q2 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
767517 | USD |
CY2018Q4 | us-gaap |
Liabilities Noncurrent
LiabilitiesNoncurrent
|
746725 | USD |
CY2018Q2 | us-gaap |
Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
92532 | USD |
CY2018Q4 | us-gaap |
Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
|
91503 | USD |
CY2018Q2 | us-gaap |
Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
|
165000 | USD |
CY2018Q4 | us-gaap |
Line Of Credit Facility Fair Value Of Amount Outstanding
LineOfCreditFacilityFairValueOfAmountOutstanding
|
201575 | USD |
CY2017Q4 | us-gaap |
Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
|
10175 | USD |
us-gaap |
Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
|
20511 | USD | |
CY2018Q4 | us-gaap |
Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
|
3035 | USD |
us-gaap |
Line Of Credit Facility Periodic Payment Interest
LineOfCreditFacilityPeriodicPaymentInterest
|
9616 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
40000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
35288 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
485294 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-6506 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-281201 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-248694 | USD | |
CY2017Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
711220 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
650699 | USD | |
CY2018Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-217983 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-265719 | USD | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
432834 | USD | |
CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
1278423 | USD |
CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
178316 | USD |
CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
|
183892 | USD |
CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
178535 | USD |
CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
182972 | USD |
CY2018Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
249620 | USD |
CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
268469 | USD |
CY2018Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
|
286239 | USD |
CY2018Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
237600 | USD |
us-gaap |
Other Income
OtherIncome
|
1000000 | USD | |
us-gaap |
Other Income
OtherIncome
|
0 | USD | |
CY2018Q2 | us-gaap |
Other Long Term Notes Payable
OtherLongTermNotesPayable
|
18037 | USD |
CY2018Q4 | us-gaap |
Other Long Term Notes Payable
OtherLongTermNotesPayable
|
16412 | USD |
CY2017Q4 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
500000 | USD |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
500000 | USD | |
CY2018Q4 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
11122 | USD |
us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
11122 | USD | |
CY2018Q2 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
3153 | USD |
CY2018Q4 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
3491 | USD |
us-gaap |
Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
|
500000 | USD | |
us-gaap |
Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
|
0 | USD | |
us-gaap |
Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
|
12500 | USD | |
us-gaap |
Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
|
0 | USD | |
us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
2206 | USD | |
us-gaap |
Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
|
6506 | USD | |
CY2018Q2 | us-gaap |
Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
|
101891 | USD |
CY2018Q4 | us-gaap |
Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
|
101891 | USD |
CY2018Q2 | us-gaap |
Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
|
749480 | USD |
CY2018Q4 | us-gaap |
Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
|
730313 | USD |
CY2018 | us-gaap |
Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
|
19368 | USD |
us-gaap |
Preferred Stock Amount Of Preferred Dividends In Arrears
PreferredStockAmountOfPreferredDividendsInArrears
|
45379 | USD | |
CY2017Q4 | us-gaap |
Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
|
0 | USD |
us-gaap |
Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
|
0 | USD | |
CY2018Q4 | us-gaap |
Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
|
13006 | USD |
us-gaap |
Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
|
26011 | USD | |
CY2018Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2018Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
CY2018Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | shares |
CY2018Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | shares |
CY2018Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
2000000 | shares |
CY2018Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
2000000 | shares |
CY2018Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
2000000 | shares |
CY2018Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
645000 | USD |
CY2018Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
645000 | USD |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
100000 | USD | |
us-gaap |
Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
|
0 | USD | |
us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
36575 | USD | |
CY2018Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
76268 | USD |
CY2018Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
67672 | USD |
CY2017Q3 | us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
545000 | USD |
CY2018Q3 | us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
100000 | USD |
CY2018Q2 | us-gaap |
Related Party Transaction Due From To Related Party
RelatedPartyTransactionDueFromToRelatedParty
|
645000 | USD |
CY2018Q3 | us-gaap |
Related Party Transaction Rate
RelatedPartyTransactionRate
|
0.0125 | |
CY2018Q3 | us-gaap |
Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
|
201575 | USD |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | USD | |
us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
1287 | USD | |
CY2018Q4 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
201575 | USD |
CY2018Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2412255 | USD |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2146536 | USD |
CY2017Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7551430 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7551430 | shares | |
CY2018Q4 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7415329 | shares |
us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
7415329 | shares | |
us-gaap |
Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
|
60000 | USD | |
CY2017Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
107509 | USD |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
300590 | USD | |
CY2018Q4 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
226338 | USD |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
322746 | USD | |
CY2017Q2 | us-gaap |
Restricted Cash
RestrictedCash
|
0 | USD |
CY2017Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
0 | USD |
CY2018Q2 | us-gaap |
Restricted Cash
RestrictedCash
|
250000 | USD |
CY2018Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
251572 | USD |
CY2018Q2 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
250000 | USD |
CY2018Q4 | us-gaap |
Restricted Cash Current
RestrictedCashCurrent
|
251572 | USD |
CY2018Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-67942203 | USD |
CY2018Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-68207922 | USD |
CY2017Q4 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
3174742 | USD |
us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
5601234 | USD | |
CY2018Q4 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
2197050 | USD |
us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
4219433 | USD | |
CY2017Q4 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
3383028 | USD |
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
6012652 | USD | |
CY2018Q4 | us-gaap |
Sales Revenue Net
SalesRevenueNet
|
2418880 | USD |
us-gaap |
Sales Revenue Net
SalesRevenueNet
|
4677263 | USD | |
CY2017Q4 | us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
208286 | USD |
us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
411418 | USD | |
CY2018Q4 | us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
221830 | USD |
us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
457830 | USD | |
CY2017Q4 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1192624 | USD |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2189129 | USD | |
CY2018Q4 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
1138916 | USD |
us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
2141153 | USD | |
CY2018Q2 | us-gaap |
Short Term Borrowings
ShortTermBorrowings
|
165000 | USD |
CY2017Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7551430 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7551430 | shares | |
CY2018Q4 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7415329 | shares |
us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
7415329 | shares | |
us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">     Escalon Medical Corp. ("Escalon" or "Company") is a Pennsylvania corporation initially incorporated in California in 1987, and reincorporated in Pennsylvania in November 2001. Within this document, the “Company” collectively shall mean Escalon, which includes its division called "Trek" and its wholly owned subsidiaries: Sonomed, Inc. (“Sonomed”), Escalon Digital Solutions, Inc. (“EMI”), Escalon Holdings, Inc. (“EHI”), Escalon IP Holdings, Inc., and Sonomed IP Holdings, Inc. </font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:Arial;font-size:9pt;"></font><font style="font-family:inherit;font-size:10pt;">The Company operates in the healthcare market, specializing in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the area of ophthalmology. The Company and its products are subject to regulation and inspection by the United States Food and Drug Administration (the “FDA”). The FDA and other government authorities requires extensive testing of new products prior to sale and has jurisdiction over the safety, efficacy and manufacture of products, as well as product labeling and marketing.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The unaudited condensed consolidated financial statements included herein have been prepared pursuant to the rules and regulations of the Security and Exchange Commission, and reflect all adjustments (consisting of only normal and recurring adjustments) which are, in the opinion of management, necessary to present fairly the unaudited condensed consolidated financial information required herein. Certain information and note disclosures normally included in financial statement prepared in accordance with accounting principles generally accepted in the United Statements of America ("US GAAP") have been condensed or omitted pursuant to such rules and regulations. While management believes that the disclosures are adequate to make the information presented not misleading, it is suggested that these unaudited condensed consolidated financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K filed with the Security and Exchange Commission for the fiscal year ended June 30, 2018.</font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> The Company’s common stock trades on the OTCQB Market under the symbol “ESMC.”</font></div></div> | ||
us-gaap |
Reclassifications
Reclassifications
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">.</font></div></div> | ||
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that impact the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div> |